India’s Chemicals Bet Isn’t Over, It’s Just Getting More Selective

As part of our smallcase rebalance reading this month, we analysed sector-level trends better to understand evolving risks and opportunities for our portfolios. This article examines the evolving landscape of India’s specialty chemicals industry, a sector navigating subdued exports, volatile margins, and a strategic shift toward high-value platforms.

The Q4FY25 performance of India’s specialty chemicals sector painted a mixed picture, tempered growth amid external challenges, margin volatility, and cautious optimism rooted in product innovation, capacity expansion, and a pivot to high-value chemistries.

1. Demand Environment: Subdued but Pockets of Strength
Domestic demand held up well for companies like Pidilite, Fine Organic, and Rossari, particularly in B2B, personal care, agrochemical, and institutional segments. However, Asian Paints and PCBL faced volume softness, impacted by weak consumer sentiment, downtrading, and sluggish B2B activity. Export-facing players like PI Industries, PCBL, and Vinati Organics encountered pricing pressure and muted realisations in overseas markets.

2. Margins: A Tightrope Walk
Raw material cost fluctuations continued to pressure gross margins for companies like Fine Organic, Rossari, and PCBL, with the latter particularly hurt by cheap Russian dumping in carbon black markets. On the flip side, Pidilite and Gujarat Fluorochemicals (GFL) saw gross margin expansion due to better pricing power and favourable input costs, while Vinati Organics saw modest margin compression amid portfolio expansion.

3. Segmental Trends: Niche Leadership Emerges
Fluoropolymers & Battery Chemicals (GFL) and HALS (Clean Science) emerged as high-growth platforms, with strong investment and ambitious volume guidance. ATBS, Antioxidants & Butyl Phenol segments (Vinati Organics) posted robust growth and are expected to remain the key value drivers over the next 2–3 years. Custom Synthesis (CSM) and pharma CRDMO at PI Industries showed promise despite near-term headwinds, supported by a solid R&D pipeline and global client additions.

4. Capex & Strategic Investments: Fueling the Next Phase
Across the board, companies are doubling down on capex:

• Asian Paints revised the Dahej project cost upward to ₹3,250 crore
• Clean Science, GFL, and Rossari announced aggressive capex plans, targeting FY26 commissioning
• Vinati and PCBL committed capital toward platform scaling (Veeral Organics, specialty blacks)
• PI Industries maintained ₹800-900 crore capex for FY26, mainly to deepen pharma and agchem offerings

5. Exports & Global Positioning: Selective Momentum
While export growth was uneven, Rossari, PCBL, and Clean Science are expanding geographically, structural headwinds in the EU and US markets weighed on volumes and realisations. Strategic moves like PCBL’s EU/SEA penetration and Clean Science’s HALS export strategy aim to improve positioning over the medium term.

Conclusion: A Consolidating Year with Growth Tailwinds Ahead
Despite cost pressures, volume volatility, and regulatory uncertainties, Indian specialty chemical players are investing in resilience and scale. With supply-chain de-risking, diversified end-use exposure, and strategic capex plans in motion, the sector is well poised for a margin and volume revival from H2FY26, especially if global demand normalises and domestic macros remain supportive.

This article is intended solely for informational purposes and is based on publicly available data and reports. While every effort has been made to ensure accuracy and reliability, the content should not be construed as investment advice or a research recommendation. Readers are advised to exercise their own judgment and discretion before making any decisions based on this content. This does not constitute a recommendation to buy, sell, or hold any securities and should not be interpreted as such under SEBI (Research Analyst) Regulations, 2014.

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of a SEBI recognized supervisory body (if any) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The content in these posts/articles is for informational and educational purposes only and should not be construed as professional financial advice and nor to be construed as an offer to buy /sell or the solicitation of an offer to buy/sell any security or financial products.Users must make their own investment decisions based on their specific investment objective and financial position and using such independent advisors as they believe necessary. Windmill Capital Team: Windmill Capital Private Limited is a SEBI registered research analyst (Regn. No. INH200007645) based in Bengaluru at No 51 Le Parc Richmonde, Richmond Road, Shanthala Nagar, Bangalore, Karnataka – 560025 creating Thematic & Quantamental curated stock/ETF portfolios. Data analysis is the heart and soul behind our portfolio construction & with 50+ offerings, we have something for everyone. CIN of the company is U74999KA2020PTC132398. For more information and disclosures, visit our disclosures page here.